ProMIS Neurosciences annual shares outstanding
2021
2022
2023
2024
2025
ProMIS Neurosciences Shares Outstanding History (PMN)
ProMIS Neurosciences reported 2.2M shares outstanding at the end of fiscal 2025.
View full ProMIS Neurosciences company overviewProMIS Neurosciences annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.2M | 844,877 | +64.62% |
| 2024 | 2024-12-31 | 1.3M | 552,109.84 | +73.09% |
| 2023 | 2023-12-31 | 755,410.16 | 412,238.8 | +120.13% |
| 2022 | 2022-12-31 | 343,171.36 | 55,350.2 | +19.23% |
| 2021 | 2021-12-31 | 287,821.16 | — | — |
ProMIS Neurosciences quarterly shares outstanding
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 9.0M | 7.7M | +585.83% |
| Q1 2026 | 2026-03-31 | 9.0M | 7.7M | +585.83% |
| Q4 2025 | 2025-12-31 | 2.2M | 844,829.4 | +64.61% |
| Q3 2025 | 2025-09-30 | 2.2M | 844,876.8 | +64.61% |
| Q2 2025 | 2025-06-30 | 1.3M | 549,122.96 | +72.40% |
| Q1 2025 | 2025-03-31 | 1.3M | 549,122.96 | +72.40% |
| Q4 2024 | 2024-12-31 | 1.3M | 552,157.44 | +73.09% |
| Q3 2024 | 2024-09-30 | 1.3M | 566,557.44 | +76.46% |
| Q2 2024 | 2024-06-30 | 758,444.64 | 415,273.28 | +121.01% |
| Q1 2024 | 2024-03-31 | 758,444.64 | 415,273.28 | +121.01% |
| Q4 2023 | 2023-12-31 | 755,410.16 | 412,238.8 | +120.13% |
| Q3 2023 | 2023-09-30 | 741,010.16 | 453,189 | +157.46% |
| Q2 2023 | 2023-06-30 | 343,171.36 | 55,350.2 | +19.23% |
| Q1 2023 | 2023-03-31 | 343,171.36 | 55,350.2 | +19.23% |
| Q4 2022 | 2022-12-31 | 343,171.36 | — | — |
| Q3 2022 | 2022-09-30 | 287,821.16 | — | — |
| Q2 2022 | 2022-06-30 | 287,821.16 | — | — |
| Q4 2021 | 2021-12-31 | 287,821.16 | — | — |
ProMIS Neurosciences shares outstanding trends
Across the available reported history, ProMIS Neurosciences's shares outstanding moved from 1.3M to 2.2M, a change of 844,877. The latest reported quarter, Q2 2026, shows 9.0M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ProMIS Neurosciences filings at SEC.gov ↗